Skip to content
MedsAcross

Medicine

Tridacaine II 50 mg/g patch

Lidocaine · Topical · Trifluent Pharma
Available on requestPrescription onlyUS FDA

Tridacaine II 50 mg/g patch is a prescription medicine containing Lidocaine for topical use, marketed by Trifluent Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25° C (68° to 77° F).

Key facts

Active ingredient (INN)
Lidocaine
Brand
Tridacaine II
Strength
50 mg/g
Dosage form
Patch
Route
Topical
Marketing authorisation holder
Trifluent Pharma
Manufacturer
Trifluent Pharma
Origin register
US FDA, United States
Storage
Store at 20° to 25° C (68° to 77° F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C01BB01 Lidocaine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
20 May 2024
Identifiers
RxCUI 1745091, 2678310DailyMed set ID 1e940ba6-3916-4fc4-8886-481fc9685fc1NDC 73352-830Application ANDA200675

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

No pack sizes are recorded. Pack size and quantity are confirmed on the quote.

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 19 November 1948Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Lidocaine 50 mg/g patch.

Compare all 10

Other strengths and forms of Lidocaine

10 mg/1 mL injection10 mg/mL injection100 mg/10 mL injection100 mg/5 mL injection1000 mg/50 mL injection150 mg/10 mL injection20 mg/1 mL injection20 mg/2 mL injection20 mg/mL jelly20 mg/mL oral solution20 mg/mL solution20 mg/mL topical solution200 mg transdermal system200 mg/10 mL injection200 mg/20 mL injection200 mg/5 mL injection2000 mg/250 mL injection2000 mg/500 mL injection250 mg/50 mL injection300 mg/20 mL injection300 mg/30 mL injection35 mg/mL ophthalmic gel36 mg patch40 mg/2 mL injectionSee all 84 presentations

Clinical summary

Lidocaine is an amide local anesthetic. It is available as injection, ointment and patches for infiltration, perineural and topical use. MedsAcross supplies Lidocaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Lidocaine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Tridacaine II 50 mg/g patch for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.

Request a quoteRead the import guides